LC-ESI–MS/MS determination of defactinib, a novel FAK inhibitor in mice plasma and its application to a pharmacokinetic study in mice-Reference-Cited by-同舟云学术

LC-ESI–MS/MS determination of defactinib, a novel FAK inhibitor in mice plasma and its application to a pharmacokinetic study in mice

Published:2018-02 Issue: Volume:149 Page:358-364
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Hallur Gurulingappa,Tamizharasan Natarajan,Sulochana Suresh P.,Saini Neeraj Kumar,Zainuddin Mohd,Mullangi Ramesh

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference7 articles.

1. Mechanism of cell–cell adhesion complex assembly;Troyanovsky;Curr. Opin. Cell. Biol.,1999

2. Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions;Schaller;J.Cell Sci.,2010

3. Focal adhesion kinase as a cancer therapy target;Golubovskaya;Anticancer Agents Med. Chem.,2010

4. Focal adhesion kinase inhibitors in the treatment of metastatic cancer: a patent review;Shanthi;Expert Opin. Ther. Pat.,2014

5. Phase II study of defactinib, VS-6063, a focal adhesion kinase (FAK) inhibitor, in patients with KRAS mutant non-small lung cancer (NSLC);Gerber,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and biological evaluation of 2,4-diamino pyrimidine derivatives as potent FAK inhibitors with anti-cancer and anti-angiogenesis activities;European Journal of Medicinal Chemistry;2021-10

2. Inhibiting Focal Adhesion Kinase Ameliorates Cyst Development in Polycystin-1–Deficient Polycystic Kidney Disease in Animal Model;Journal of the American Society of Nephrology;2021-08-31

3. Interpretation of MS–MS spectra of small-molecule signal transduction inhibitors using accurate-m/z data and m/z-shifts with stable-isotope-labeled analogues and metabolites;International Journal of Mass Spectrometry;2021-06

4. Development and validation of an UHPLC-MS/MS method for simultaneous determination of palbociclib, letrozole and its metabolite carbinol in rat plasma and pharmacokinetic study application;Arabian Journal of Chemistry;2020-02

5. Simultaneous determination of illegal drug substances in dietary supplements for gout and osteoporosis using ultra-performance liquid chromatography and liquid chromatography-quadrupole-time-of-flight mass spectrometry;Journal of Pharmaceutical and Biomedical Analysis;2020-02